Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610717-25-000229
Filing Date
2025-06-13
Accepted
2025-06-13 18:50:52
Documents
1
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3786
  Complete submission text file 0001610717-25-000229.txt   5515
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus Oncology, Inc. (Issuer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O COHERUS BIOSCIENCES, INC. 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY CA 94065
Business Address
O'Donnell-Tormey Jill (Reporting) CIK: 0001927733 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36721 | Film No.: 251048056